NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 389 filers reported holding NOVAVAX INC in Q1 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233 | +301.7% | 16,193 | +105.7% | 0.00% | – |
| Q2 2023 | $58 | +5.5% | 7,873 | 0.0% | 0.00% | – |
| Q1 2023 | $55 | -32.1% | 7,873 | 0.0% | 0.00% | – |
| Q4 2022 | $81 | -99.9% | 7,873 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $143,000 | -64.7% | 7,873 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $405,000 | -30.2% | 7,873 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $580,000 | -48.5% | 7,873 | 0.0% | 0.00% | -40.0% |
| Q4 2021 | $1,126,000 | -31.0% | 7,873 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $1,632,000 | -2.4% | 7,873 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $1,672,000 | +17.2% | 7,873 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $1,427,000 | +62.5% | 7,873 | 0.0% | 0.01% | +75.0% |
| Q4 2020 | $878,000 | +2.9% | 7,873 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $853,000 | +30.0% | 7,873 | 0.0% | 0.01% | +25.0% |
| Q2 2020 | $656,000 | – | 7,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |